Mauro Bavetta

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
OBJECTIVES The aim of this study was to evaluate clinical and US-PD parameters in PsA during adalimumab treatment. METHODS A retrospective study has been conducted in forty patients affected by moderate-to-severe peripheral PsA. Clinical, laboratory, and US-PD evaluations were performed at baseline, after 4, 12, and 24 weeks of treatment. They included(More)
The genetic basis of predisposition to psoriasis is recognised; however, the response to psoriasis treatment in patients with different genetic predisposition is poorly understood. To analyse the presence of the HLA-C*06:02 polymorphism in psoriatic patients treated with adalimumab. Genomic DNA was extracted from whole blood of 122 patients with(More)
  • 1